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Research
Acute, high-level exposure to some organo-
phosphate (OP) pesticides is known to result 
in delayed peripheral neuropathy (Lotti and 
Moretto 2005); however, the peripheral nervous 
system (PNS) effects of long-term exposure at 
levels insufficient to cause clinical toxicity are 
more controversial. Most research has focused 
on the central nervous system effects of long-
term OP pesticide exposure, with most studies 
of non  poisoned individuals reporting increases 
in neurological symptoms or impaired neuro-
behavioral function after OP exposure (Kamel 
and Hoppin 2004). Few studies have examined 
associations between OP pesticide application 
and PNS function (Cole et al. 1998; London 
et al. 1998; Pilkington et al. 2001; Steenland 
et al. 2000; Stokes et al. 1995), and only one 
examined associations among participants with-
out prior pesticide poisoning (Steenland et al. 
2000). The results of these studies vary, possibly 
because of differences in exposure characteriza-
tion, comparison populations and measures of 
PNS function in addition to small sample sizes 
(Kamel and Hoppin 2004; Lotti 2002).
The purpose of this epidemiological inves-
tigation was to examine cumulative lifetime use 
of specific OP pesticides and measures of PNS 
function in a large sample of pesticide applica-
tors with well-characterized lifetime pesticide 
exposure. The primary hypothesis was that 
long-term OP pesticide use is associated with 
adverse peripheral neurological outcomes.
Methods
Study population. We conducted neurological 
testing on 701 participants in the Agricultural 
Health Study (AHS), a large prospective study 
of licensed pesticide applicators from Iowa and 
North Carolina (Alavanja et al. 1996). Male 
AHS participants were invited to participate 
in the present study based on their lifetime 
use of OPs, completion of earlier parts of the 
study, and proximity to the testing sites.
The AHS enrolled private pesticide 
applicators between 1993 and 1997 when they 
completed a self-administered “enrollment” 
questionnaire at the time of pesticide 
licensing and recertification; 44% of private 
pesticide applicators also completed a take-
home questionnaire. These two questionnaires 
comprised phase 1 data collection. After 
enrollment, two 5-year follow-up phone 
interviews were administered (phase 2 and 
3 data collection). The present study sample 
is limited to those who completed all AHS 
questionnaires. The questionnaires are 
available online (AHS 2011).
To enrich the sample with applicators 
with higher lifetime use of OP pesticides, we 
oversampled the high end of the OP lifetime 
use distribution based on the lifetime days of 
use of 10 OPs assessed in detail in phase 1. 
Among eligible participants, a stratified sam-
ple was selected based on equal random sam-
pling from the upper and lower portions of 
the OP lifetime days distribution. In Iowa, a 
cut point of approximately 75% was used to 
separate individuals; in North Carolina the 
cut point was lower (66%) because the North 
Carolina cohort is more geographically dis-
persed and has fewer members. Although the 
cut point was shifted for selection, all analyses 
were based on lifetime use of pesticides. Thus, 
although the sampling frame allowed for a 
sample enriched for OP use, it was not used as 
an analytical variable.
For the present study, AHS participants 
with amyotrophic lateral sclerosis, diabetes, 
multiple sclerosis, Parkinson’s disease, retinal 
or macular degeneration, hypo  thyroidism, and 
stroke were excluded. In addition, participants 
who, during phase 3 AHS interviews, reported 
drinking ≥ 42 alcoholic beverages/week or 
reported being diagnosed with pesticide poi-
soning were excluded. After exclusions, a total 
of 1,807 AHS participants were initially eli-
gible to participate. The overall participation 
rate was 39%.
In Iowa, testing was conducted in Iowa 
City and Dubuque between November 2006 
and March 2007. In North Carolina, testing 
was conducted in Greenville and Wilmington 
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Ba c k g r o u n d: Evidence is limited that long-term human exposure to organophosphate (OP) 
  pesticides, without poisoning, is associated with adverse peripheral nervous system (PNS) function.
oB j e c t i v e: We investigated associations between OP pesticide use and PNS function by adminis-
tering PNS tests to 701 male pesticide applicators in the Agricultural Health Study (AHS).
Me t h o d s : Participants completed a neurological physical examination (NPx) and electrophysio-
logical tests as well as tests of hand strength, sway speed, and vibrotactile threshold. Self-reported 
information on lifetime use of 16 OP pesticides was obtained from AHS interviews and a study 
questionnaire. Associations between pesticide use and measures of PNS function were estimated 
with linear and logistic regression controlling for age and outcome-specific covariates. 
re s u l t s: Significantly increased odds ratios (ORs) were observed for associations between ever use 
of 10 of the 16 OP pesticides and one or more of six NPx outcomes. Most notably, abnormal toe 
proprioception was significantly associated with ever use of 6 OP pesticides, with ORs ranging from 
2.03 to 3.06; monotonic increases in strength of association with increasing use was observed for 3 
of the 6 pesticides. Mostly null associations were observed between OP pesticide use and electro-
physiological tests, hand strength, sway speed, and vibrotactile threshold.
co n c l u s i o n s: This study provides some evidence that long-term exposure to OP pesticides is asso-
ciated with signs of impaired PNS function among pesticide applicators.
key w o r d s : agricultural workers, neurological testing, occupational exposure, organophosphates, 
pesticide exposure. Environ Health Perspect 120:515–520 (2012).  http://dx.doi.org/10.1289/
ehp.1103944 [Online 19 January 2012]Starks et al.
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between January and March 2008. Institutional 
review boards approved the study protocol, 
and all participants provided written informed 
consent.
Exposure assessment. For each participant, 
pesticide use information from the three AHS 
phases and a questionnaire administered on 
the day of neurological testing was used to cre-
ate ever use and lifetime days of use variables 
for the 16 OP pesticides used by at least 50 
neurological study participants. Ever use was 
based on any report of use at any interview, 
and lifetime days of use was based on the sum 
of lifetime days of use calculated for each inter-
view period.
Pesticide use information was assessed in 
slightly different ways in each AHS phase. 
In phase 1 questionnaires, participants were 
queried in detail about 50 pesticides and asked 
to provide information on ever use, frequency 
of use, and years of use. Additionally, on the 
phase 1 take-home questionnaire, participants 
were asked to complete a checklist indicating 
ever use of specific chemicals but were not 
asked about frequency or duration of use. In 
phases 2 and 3, participants provided open-
ended responses about their pesticide use 
since the last interview, and their responses 
were used to create lifetime use information 
for those time periods. The questionnaire 
adminis  tered on the day of neurological test-
ing collected pesticide use information for the 
past 12 months. Of the 16 pesticides included 
in the present study, 9 were reported in detail 
on the AHS phase 1 questionnaires (chlorpyri-
fos, coumaphos, diazinon, dichlorvos, fonofos, 
malathion, parathion, phorate, and terbufos); 
6 were initially queried on the phase 1 take-
home questionnaire checklist (acephate, dime-
thoate, disulfoton, ethoprop, phosmet, and 
tetrachlorvinphos); and a new chemical intro-
duced in 1995 (tebupirimfos) was reported 
initially on the phase 2 questionnaire.
For phase 1 lifetime days of use, we mul-
tiplied the number of days used per year by 
the numbers of years used to create the sum-
mary measure. Because this information was 
not available for the chemicals listed on the 
take-home checklist, we assumed that the days 
per year applied was equal to the median num-
ber of days of insecticide use per year for that 
individual and that the number of years used 
was equal to the median number of years that 
individual had applied insecticides using the 
categories in the phase 1 questionnaire. These 
values were used to create an estimate of life-
time days of use in phase 1 for the chemicals 
listed in the take-home checklist. For phases 2 
and 3 as well as the neurological study ques-
tionnaire, we multiplied the number of days 
used per year by the number of years since the 
last interview to create the lifetime days for that 
period. We then summed the lifetime days for 
phase 1–3 questionnaires and the neurological 
study questionnaire to create cumulative life-
time days of use for each pesticide. All pesticide 
use occurred prior to neurological testing. A 
summary measure of OP pesticide use (cumu-
lative lifetime days of all OP pesticides) was 
also created.
We created similar variables for the four car-
bamate pesticides (aldicarb, benomyl, carbaryl, 
and carbofuran). In addition, an overall measure 
of cumulative lifetime pesticide use (all chemical 
classes) was estimated from all AHS interviews 
for the 50 pesticides assessed on the AHS enroll-
ment questionnaire. Finally, information on 
high pesticide exposure events (HPEEs) was 
obtained from three AHS interviews.
In summary, for every participant, pesti-
cide exposures were characterized as a) ever use 
of 16 OP and 4 carbamate pesticides, b) cumu-
lative lifetime days of use for each of these pes-
ticides, c) cumulative lifetime days of any OP 
pesticide use, d) cumulative lifetime days of 
any pesticide use, and e) ever having an HPEE.
Neurological outcomes. The purpose of the 
neurological evaluation was to assess neuro-
logical function rather than to diagnose clini-
cally apparent peripheral neuropathy.
Neurological physical examination. 
Standard neurological physical examinations 
(NPxs) (Campbell 2005) were performed by 
a physician (F.G.) blinded to pesticide expo-
sure status. Assessments of vibration perception 
(128 Hz) and proprioception were performed 
on the great toes, bilaterally. Achilles deep ten-
don reflexes were examined bilaterally, and 
Romberg test performance, tandem gait, and 
postural tremor were assessed.
Clinical examination results were recorded 
as normal, equivocal, or abnormal. For all tests 
performed bilaterally (ankle reflex, toe proprio-
ception, and toe vibration), examination results 
were classified as “abnormal” if ratings were 
abnormal or equivocal bilaterally, abnormal 
unilaterally and equivocal on the contra  lateral 
side, or abnormal unilaterally and missing 
(because of injury/amputation) on the contra-
lateral side. For tests without laterality (postural 
tremor, Romberg test, and tandem gait), we 
combined abnormal and equivocal results to 
create a dichotomized variable (normal vs. not 
normal) for each outcome.
Electrophysiological measures. Standard 
non  invasive electrophysiological measures of the 
dominant peroneal motor nerve were performed 
with a factory-calibrated TECA Sapphire II elec-
tromyograph (TECA Corp., Pleasantville, NY) 
by one examiner (F.G.) as described by Kimura 
(2001). Foot temperature was maintained above 
32°C during testing. Distal motor amplitude 
(millivolts), distal and proximal motor latency 
(milliseconds), and short F-wave latency (milli-
seconds) were obtained and nerve conduction 
velocity (meters per second) was calculated.
Hand strength. Gross grip strength and 
key and palmar pinch strength were obtained 
bilaterally using digital grip and pinch dyna-
mometers (JTech Medical, Salt Lake City, UT) 
(Mathiowetz et al. 1984). A mean z-score for 
all six hand strength tests (three tests performed 
bilaterally) combined was calculated to create 
one summary measure for hand strength.
Sway speed. Standing sway speed was 
measured with a CATSYS 2000 Force Plate 
(Danish Product Development, Snekkersten, 
Denmark) (Despres et al. 2000). Four 80-sec 
trials were administered, two with eyes open 
and two with eyes closed. Average sway speed 
(millimeters per second) is reported separately 
for eyes open and eyes closed.
Vibrotactile threshold. The Vibratron II 
(Sensortek, Inc., Clifton, NJ) was used to 
measure bilateral great toe 120-Hz vibrotactile 
threshold with a standard protocol (Gerr et al. 
1990). A single bilateral mean vibrotactile 
threshold is reported in log micrometers.
Assessment of potential confounders. Age, 
height, state (Iowa or North Carolina), smok-
ing status (never, current, or past), education 
(≤ high school or > high school), alcohol use 
(0, 1–7, or > 7 drinks/week), ear infection 
within the past 12 months, prior inner ear sur-
gery, exposure to other potentially neurotoxic 
substances such as solvents, soldering, and 
welding fumes (ever used ≥ 8 hr/week), and 
body mass index (BMI; kilograms per meter 
squared) were assessed for potential confound-
ing of associations between pesticide use and 
PNS outcomes.
Study participant exclusions. Participants 
were excluded from all PNS analyses because 
of past polio (n = 6), cancer chemotherapy 
(n = 4), alcohol consumption on the day of test-
ing (n = 3), physician diagnosis of alcoholism 
(n = 3), reporting drinking ≥ 42 alcoholic bever-
ages/week during the past year (n = 3), diabetes 
(n = 1), dialysis (n = 1), severe dementia (n = 1), 
and being struck by lightning (n = 1).
Results of all tests except the electro  physio-
logical tests were excluded for 5 participants 
with a history of brain tumor. For tests of pos-
tural stability, we excluded 2 participants who 
reported current use of the drug meclizine and 
2 with Ménière’s disease. Electrophysiological 
results of 2 participants were excluded after 
linear regression diagnostics showed studen-
tized residuals with absolute values > 6.0. In 
addition, a small number of participants were 
unable to perform certain tests because of 
recent surgery, amputation, or injury.
Statistical methods. Logistic regression 
was used to estimate odds ratios (ORs) of 
association between pesticide use and dichoto-
mized NPx results. A base model with no pes-
ticide exposure variables was developed using 
backward elimination. Adjusted models were 
run separately for each individual pesticide 
parameterized as ever use versus never use. 
Exposure response was examined by creating 
a three-level variable for individual pesticides Pesticides and peripheral nervous system function
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with the distribution of lifetime days of use 
split at the median among the pesticide users 
to create two exposure categories (≤ median, 
and > median), with never use as the referent 
category. The distributions of the pesticide 
summary variables lifetime days of all OP pes-
ticides and lifetime days of all pesticides were 
split in quartiles with the lowest category as 
the referent group. Chi-square tests for trend 
were used for all exposure–response models 
with exposure levels assigned 0, 1, and 2 for 
non  exposed, ≤ the median, and > the median. 
Analyses were restricted to pesticides with at 
least five exposed cases per category.
Linear regression was used to examine 
associations between pesticide use and the 
continuous outcomes. A base model for each 
neurological outcome was created with an out-
come-specific set of covariates using backward 
elimination. The final multivariate base model 
for each outcome included only those covariates 
with p-values < 0.20. Each pesticide was exam-
ined both as a dichotomized variable (ever/never 
use) and as a continuous variable. The cumula-
tive lifetime days of pesticide use variables were 
log10 transformed to normalize the distribu-
tion of residuals. Adjusted associations between 
neurological outcomes and pesticide exposures 
were estimated with linear regression models in 
which the neurological outcome was regressed 
on the pesticide exposure variable while con-
trolling for base model covariates. For greater 
ease of interpretation, parameter estimates for 
peroneal nerve distal motor latency and short 
F-wave latency, sway speed, and vibrotactile 
threshold were multiplied by –1 so that lower 
scores indicated poorer performance for all 
  continuous outcomes.
We examined potential confounding of 
the association between neurological out-
comes and each pesticide by other pesticides 
in both linear and logistic regression models. 
Specifically, pesticide pairs with r ≥ 0.30 were 
added simultaneously to final base models, and 
the pesticide variable parameter estimates were 
compared with models with one pesticide.
To evaluate whether associations between 
pesticide use and neurological outcomes were 
influenced by previous pesticide poisoning, 
the 8 participants who reported ever being 
physician diagnosed with pesticide poisoning 
at the time of AHS enrollment were excluded 
from the analyses, and the results were com-
pared with models that included them. The 
results did not change.
All analyses were performed using SAS 
software (version 9.2; SAS Institute Inc., 
Cary, NC).
Results
A total of 701 individuals participated in neuro-
logical testing; 23 were excluded, resulting in 
678 included in these analyses. The mean ± SD 
age of the participants was 61 ± 11.6 years 
(Table 1). Approximately half of the partici-
pants reported completing at least a high school 
education. Nearly all participants reported 
ever using any OP [98%; see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1103944)]. Proportions of applicators 
reporting use of specific OPs ranged from 
77% for malathion to < 10% for dimethoate, 
tebupirimfos, and tetrachlorvinphos. NPx signs 
and electrophysiological and quantitative func-
tional PNS test results were consistent with 
clinical expectation for the age of the sample. 
Descriptive statistics for these outcomes are pre-
sented in Supplemental Material, Table 2.
Base model covariates. Age was included in 
all neurological outcome models, and height 
was included in all models except for ankle 
reflex and postural tremor. The total variance 
(R2) accounted for by linear regression models 
ranged from 0.16 for distal motor amplitude to 
0.40 for hand strength. Base model covariates 
for the linear and logistic regression models are 
presented in Supplemental Material, Table 3 
(http://dx.doi.org/10.1289/ehp.1103944).
NPx results. Overall, ever use of 10 of the 
16 OP pesticides was associated with one or 
more of the six NPx outcomes (Table 2). Six 
OPs were associated with toe proprioception 
abnormality, and 1 OP was inversely associ-
ated with toe proprioception abnormality [i.e., 
upper bound of the 95% confidence interval 
(CI) ≤ 1.0]. Four OPs were associated with 
postural tremor abnormality, and 1 OP was 
inversely associated with postural tremor 
abnormality. The only overlap between these 
two outcomes was for ethoprop, which was 
associated with postural tremor abnormality 
and inversely associated with toe propriocep-
tion abnormality. The three-level exposure 
response models were generally consistent 
with the ever-use models [see Supplemental 
Material, Table 4 (http://dx.doi.org/10.1289/
ehp.1103944)]. All 4 carbamate pesticides 
were inversely associated with NPx abnormali-
ties. No significant associations were observed 
between NPx results and lifetime days of all 
OP pesticides or lifetime days of all pesticides 
(data not shown). Results for each NPx out-
come are presented below.
Ankle reflex. Ever use of phosmet and of 
tebupirimfos were significantly associated with 
ankle reflex abnormality, whereas ever use of 
aldicarb was inversely associated with ankle 
reflex abnormality. In dose–  response models, 
a significant monotonic increase in ORs was 
observed for fonofos and phosmet. There was 
insufficient data to evaluate tebupirimfos in 
dose–response models. There was no evidence 
of a monotonic dose response for aldicarb.
Postural tremor. Elevated ORs were 
observed for ever use of dimethoate, disulfoton, 
ethoprop, and tebupirimfos and postural tremor 
abnormality. Tests for trend were signifi  cant 
for dimethoate, disulfoton, ethoprop, and 
tebupirimfos, whereas the increase in ORs for 
disulfoton was not monotonic. Although ever 
use of diazinon was associated with a reduced 
OR, there was no evidence of a dose response.
Romberg test. We observed an inverse 
association for ever use of carbofuran and 
Romberg test abnormality with no significant 
test for trend.
Tandem gait. Dichlorvos use was associated 
with tandem gait abnormality, and whereas the 
test for trend was significant, the increase across 
ORs was not monotonic. Although an elevated 
but non  significant OR for ever use of phosmet 
was observed, a significant dose–response trend 
was also observed. Ever use of acephate and 
benomyl were both inversely associated with 
tandem gait abnormality, but neither showed a 
dose response.
Toe proprioception. Ever use of chlorpy-
rifos, coumaphos, dichlorvos, fonofos, phos-
met, and tetrachlorvinphos were associated 
with toe proprioception abnormality, whereas 
ORs among users of carbaryl and ethoprop 
were below unity. In the dose–response mod-
els, chlorpyrifos, dichlorvos, fonofos, phor-
ate, phosmet, and carbaryl all had significant 
tests for trend, and all but dichlorvos showed a 
monotonic increase in ORs.
Toe vibration. Significant adverse associa-
tions were observed with ever use of dichlor-
vos and tetrachlorvinphos and toe vibration. 
Dichlorvos also had a significant dose response 
for trend. There were too few counts to evalu-
ate the dose response for tetrachlorvinphos.
Table 1. Demographic characteristics, personal 
health information, and occupational exposure 
among 678 male licensed pesticide applicators 
in the AHS.
Characteristic
Mean ± SD 
or n (%)
Age (years) 61.2 ± 11.6
Height (cm) 179.1 ± 6.4
BMI (kg/m2) 28.7 ± 4.0
Foot temperature (°C) 31.9 ± 0.8
Testing location
Iowa 342 (50.4)
North Carolina 336 (49.6)
Education
≤ High school 344 (50.7)
> High school 334 (49.3)
Smoking status
Never smoked 390 (57.5)
Current smoker 43 (6.3)
Past smoker 245 (36.1)
Alcohol consumptiona
0 drinks 389 (57.4)
1–7 drinks 225 (33.2)
> 7 drinks 64 (9.4)
Pesticide poisoning 8 (1.2)
Solvent exposureb 279 (41.2)
Soldering exposureb 34 (5.0)
Welding exposureb 136 (20.1)
Inner ear surgery 14 (2.1)
Ear infection in the previous 12 months 17 (2.5)
aThe average number of drinks/week during the past 
12 months. bEver worked ≥ 8 hr/week at a past or present 
job or at home that resulted in exposure.Starks et al.
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Electrophysiological measures. Adjusted 
regression coefficients for peroneal motor nerve 
electrophysiological measures and pesticide use 
are presented in Table 3. Overall, we observed 
more associations consistent with reduced risk 
(i.e., positive parameter estimates); however, 
few were statistically significant. Reduced 
risk estimates were observed between distal 
motor amplitude and phorate, tebupirimfos, 
and HPEEs. The dose–response models for 
phorate and tebupirimfos were consistent with 
a monotonic risk reduction for distal motor 
amplitude. Phorate was associated with faster 
nerve conduction velocity. Acephate, phorate, 
aldicarb, lifetime days of all OPs, and lifetime 
days of all pesticides showed shorter F-wave 
latency (i.e., lower risk) with increasing pes-
ticide use. Only distal motor latency showed 
increased risk with pesticide use. Greater distal 
motor latency (i.e., greater risk) was observed 
among users of diazinon and carbaryl, with 
risk increasing with increasing use.
Quantitative functional measures. We 
found no significant increases in risk between 
quantitative functional PNS tests and pesti-
cide use [see Supplemental Material, Table 5 
(http://dx.doi.org/10.1289/ehp.1103944)]. 
However, ever use and lifetime days of phos-
met use and HPEE were associated with greater 
hand strength. Both measures of parathion, 
tebupirimfos, and aldicarb use were associated 
with lower sway speed (i.e., better sway func-
tion) with eyes open. However, the association 
with lower sway speed with eyes closed was 
limited to aldicarb. Aldicarb was also associated 
with lower (better) vibrotactile threshold.
Confounding by correlated pesticide expo-
sures. Dichlorvos and coumaphos use were 
correlated in our sample. In models of toe pro-
prioception that included both pesticides, the 
OR for coumaphos and toe proprioception 
was attenuated from 2.03 to 1.44 (95% CI: 
0.71, 2.92), whereas the OR for dichlorvos 
decreased by < 10%, from 2.73 to 2.45 (95% 
CI: 1.32, 4.54). We observed no other evi-
dence of confounding by multiple pesticides.
Discussion
We observed significant associations between 
use of several OP pesticides and NPx abnor-
malities among pesticide applicators. No sin-
gle pesticide was uniformly associated with all 
neurological measures, and no one measure 
was uniformly associated with all pesticides. 
Toe proprioception was the most responsive 
NPx outcome and was associated with 6 of 16 
OP pesticides. Significant exposure–response 
relationships were observed for several pes-
ticides, suggesting that associations between 
these pesticides and toe proprioception abnor-
mality were not spurious. For most other 
outcomes, we observed mostly null associa-
tions and a few significant inverse associations 
between OP pesticide use and other PNS out-
comes. Despite the inconsistency in findings 
across the outcome measures, our results pro-
vide some evidence that long-term exposure 
to specific OP pesticides may adversely affect 
the PNS.
Published studies show considerable vari-
ability in association between OP pesticide 
exposure and PNS outcomes. Studies of PNS 
function among pesticide workers vary with 
respect to the populations studied (manufac-
turing workers to pesticide applicators), out-
comes assessed (e.g., neurological signs and 
symptoms, electrophysiological tests), expo-
sure characterization, inclusion of pesticide-
poisoned individuals, and age of participants. 
In a study of 123 OP pesticide applicators 
(mean age, 36 years) and 123 non  applicators 
(mean age, 37 years), significantly elevated 
ORs were observed for motor coordination 
signs, deep tendon reflexes, and reduced mus-
cle strength among the most heavily exposed 
applicators (Cole et al. 1998). Contrary to our 
results, Cole et al. (1998) observed a borderline 
association for vibrotactile threshold but not 
for toe vibration abnormality on NPx. In a 
study of 164 OP pesticide applicators (mean 
age = 34 years) and 83 unexposed controls 
(mean age, 33 years), neither vibro  tactile 
threshold nor tremor was associated with pes-
ticide exposure (London et al. 1998). In a 
study comparing 191 OP termiticide applica-
tors (mean age, 39 years) with 106 unexposed 
friends (mean age, 38 years) and 83 unexposed 
workers (mean age, 43 years), no difference was 
observed between applicators and either com-
parison group on NPx outcomes or measures 
of great toe vibrotactile threshold (Steenland 
et al. 2000). However, unlike the present 
study, mean sway path length was significantly 
longer among the applicators.
PNS symptoms were assessed with a 
questionnaire and quantitative measures 
of vibrotactile and thermal thresholds were 
administered to 612 “sheep-dipping” farmers 
Table 2. Adjusted ORs (95% CIs) between NPx tests and ever use of individual pesticides among 678 male pesticide applicators in the AHS.
Exposure
Ankle reflex 
(abnormal = 109, 
normal = 554)
Postural tremor 
(abnormal = 117, 
normal = 547)
Romberg 
(abnormal = 59, 
normal = 586)
Tandem gait 
(abnormal = 180, 
normal = 586)
Toe proprioception 
(abnormal = 62, 
normal = 603)
Toe vibration 
(abnormal = 120, 
normal = 554)
OPs
Acephate 0.67 (0.39, 1.16) 1.39 (0.89, 2.19) 0.84 (0.34, 2.08) 0.60 (0.37, 0.97) —  0.54 (0.25, 1.18)
Chlorpyrifos 0.81 (0.52, 1.26) 1.03 (0.68, 1.56) 1.43 (0.78, 2.62) 1.21 (0.81, 1.82) 2.35 (1.28, 4.31) 1.45 (0.91, 2.30)
Coumaphos 1.40 (0.75, 2.63) 0.93 (0.50, 1.74) 1.12 (0.50, 2.54) 1.05 (0.60, 1.89) 2.03 (1.06, 3.90) 1.27 (0.70, 2.31)
Diazinon 1.24 (0.80, 1.93) 0.63 (0.41, 0.96) 0.69 (0.38, 1.26) 1.07 (0.72, 1.58) 0.67 (0.39, 1.16) 1.02 (0.65, 1.62)
Dichlorvos 1.35 (0.78, 2.34) 0.81 (0.46, 1.40) 1.06 (0.50, 2.23) 2.29 (1.41, 3.71) 2.73 (1.53, 4.86) 1.94 (1.32, 3.31)
Dimethoate 1.20 (0.58, 2.48) 1.90 (1.01, 3.54) 0.94 (0.34, 2.59) 1.26 (0.66, 2.43) 1.86 (0.86, 4.00) 1.66 (0.83, 3.31)
Disulfoton 0.95 (0.53, 1.70) 1.95 (1.19, 3.18) 0.84 (0.33, 2.15) 0.80 (0.47, 1.35) 0.39 (0.15, 1.01) 0.67 (0.30, 1.50)
Ethoprop 1.03 (0.58, 1.80) 2.16 (1.35, 3.47) 1.52 (0.65, 3.58) 0.98 (0.59, 1.64) 0.36 (0.14, 0.93) 1.08 (0.52, 2.23)
Fonofos 1.47 (0.92, 2.34) 1.07 (0.69, 1.66) 0.90 (0.45, 1.81) 1.18 (0.77, 1.80) 3.06 (1.79, 5.25) 1.62 (0.98, 2.68)
Malathion 1.37 (0.78, 2.34) 0.88 (0.54, 1.42) 0.73 (0.37, 1.43) 0.82 (0.51, 1.31) 1.05 (0.55, 2.00) 1.20 (0.69, 2.09)
Parathion 0.95 (0.57, 1.60) 0.99 (0.61, 1.61) 0.72 (0.34, 1.50) 0.73 (0.46, 1.16) 0.34 (0.14, 0.81) 1.30 (0.75, 2.25)
Phorate 0.68 (0.42, 1.11) 0.81 (0.52, 1.26) 0.86 (0.45, 1.63) 1.05 (0.70, 1.59) 1.67 (0.97, 2.84) 0.99 (0.61, 1.60)
Phosmet 2.87 (1.52, 5.44) 0.64 (0.31, 1.29) 1.18 (0.46, 3.01) 1.71 (0.93, 3.12) 2.82 (1.47, 5.42) 0.73 (0.38, 1.41)
Tebupirimfos 2.01 (1.00, 4.05) 2.17 (1.18, 4.00) — 1.00 (0.51, 1.95) 1.84 (0.85, 4.01) 0.86 (0.42, 1.76)
Terbufos 0.95 (0.61, 1.48) 0.89 (0.59, 1.34) 0.79 (0.42, 1.47) 1.08 (0.73, 1.59) 1.25 (0.73, 2.13) 1.02 (0.64, 1.62)
Tetrachlorvinphos 1.13 (0.53, 2.34) 1.36 (0.70, 2.62) 1.68 (0.67, 4.24) 1.01 (0.50, 2.02) 2.35 (1.11, 4.98) 2.15 (1.11, 4.17)
Carbamates
Aldicarb 0.43 (0.22, 0.86) 1.37 (0.84, 2.26) 0.46 (0.16, 1.31) 1.00 (0.61, 1.65) 0.43 (0.18, 1.02) 1.09 (0.53, 2.26)
Benomyl 0.65 (0.35, 1.22) 1.26 (0.75, 2.11) 0.87 (0.35, 2.18) 0.52 (0.30, 0.90) 0.40 (0.15, 1.02) 1.28 (0.64, 2.59)
Carbaryl 0.67 (0.42, 1.06) 1.39 (0.89, 2.16) 0.74 (0.38, 1.45) 0.77 (0.51, 1.17) 0.45 (0.26, 0.77) 1.25 (0.75, 2.07)
Carbofuran 0.77 (0.50, 1.21) 0.95 (0.63, 1.42) 0.48 (0.26, 0.90) 0.95 (0.64, 1.41) 1.45 (0.85, 2.46) 1.23 (0.79, 1.93)
HPEEs 0.96 (0.56, 1.67) 1.29 (0.80, 2.08) 1.57 (0.78, 3.15) 1.03 (0.63, 1.68) 0.99 (0.51, 1.90) 0.68 (0.38, 1.21)
Ankle reflex models were adjusted for age and BMI; postural tremor models were adjusted for age; Romberg models were adjusted for age, height, and state; tandem gait models were 
adjusted for age and height; toe proprioception models were adjusted for age and height; toe vibration models were adjusted for age, height, and state. Results from models with fewer 
than five exposed cases are not presented.Pesticides and peripheral nervous system function
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exposed to OP pesticides (mostly < 55 years of 
age) and 160 unexposed referents (Pilkington 
et al. 2001). Neurological symptoms were not 
associated with total number of dipping days 
or cumulative OP exposure. Cumulative OP 
exposure was not associated with cutaneous 
temperature perception or vibrotactile thresh-
old. Handling of OP concentrate was associ-
ated with symptoms and marginally associated 
with cutaneous cold temperature perception.
Vibrotactile thresholds were measured 
among 68 male pesticide applicators in New 
York State (mostly < 50 years of age) and 68 
referents matched for age, sex, and county 
of residence (Stokes et al. 1995). Azinphos-
methyl was the most commonly used insecti-
cide. Poorer vibrotactile acuity of the fingers 
and toes was observed among the applicators.
In contrast to earlier studies of OP exposure 
and PNS function, we focused on exposure to 
specific OPs and on lifetime exposure to any 
OPs. Other studies collected data on specific 
pesticide exposures but ultimately presented 
data only for summary variables. For example, 
although Cole et al. (1998) characterized 
exposure to OP and carbamate insecticides and 
dithiocarbamate fungicides among Ecuadorian 
agricultural workers, their analyses were limited 
to comparisons of current pesticide applicators 
with non  exposed referents. Similarly, Stokes 
et al. (1995) collected questionnaire-based 
information about lifetime use of specific OPs 
among pesticide applicators in New York but 
reported only comparisons of applicators with 
referents.
In the present study, we focused on specific 
chemical exposures, rather than comparing 
pesticide applicators with non  applicators; this 
allowed us to further explore whether specific 
OPs contributed to adverse PNS function. We 
estimated cumulative lifetime exposure based 
on self-reported pesticide use information 
reported at four points in time. We relied on 
this metric of lifetime exposure as our primary 
exposure metric. In general, our results were 
similar for both ever use of a specific OP and 
continuous days of use. The fact that the con-
tinuous results were not different from the ever 
use estimates may be a result of the assump-
tions used to create the continuous exposure 
measure (e.g., potentially overestimating 
exposure and thus attenuating the exposure–
response relationship), or it may be that the 
assumption of chronic exposure as the most 
relevant exposure was incorrect and, in fact, 
intermittent higher level exposures contributed 
more to increased risk. However, such inter-
mittent exposures are not well quantified using 
our questionnaire. Or it may be that using a 
log transform of the exposure metric attenuated 
the impact of the high-end values, thus making 
it more difficult to detect associations limited 
to the high end of the distribution. Although 
the estimated metrics may be limited because 
Table 3. Adjusted regression coefficients [β (95% CI)] between electrophysiological tests and pesticide 
use (ever use and log10 lifetime days of use) among 678 male pesticide applicators in the AHS.
Exposure
Distal motor 
amplitude (mV; 
n = 664)
Distal motor 
latency (msec; 
n = 655)a
Nerve conduction 
velocity 
(m/sec; n = 652)
Short F-wave 
latency (msec; 
n = 544)a
OPs
Acephate
Ever use 0.01 (–0.53, 0.54) 0.03 (–0.14, 0.20) 0.42 (–0.42, 1.27) 1.18 (0.20, 2.16)
Lifetime days 0.05 (–0.24, 0.34) 0.02 (–0.07, 0.11) 0.22 (–0.24, 0.68) 0.73 (0.21, 1.25)
Chlorpyrifos
Ever use 0.05 (–0.33, 0.43) –0.07 (–0.20, 0.05) 0.12 (–0.48, 0.73) 0.09 (–0.60, 0.79)
Lifetime days –0.02 (–0.24, 0.19) –0.01 (–0.08, 0.05) 0.18 (–0.16, 0.53) 0.11 (–0.28, 0.50)
Coumaphos
Ever use –0.09 (–0.64, 0.46) –0.04 (–0.22, 0.13) 0.35 (–0.53, 1.24) 0.36 (–0.64, 1.37)
Lifetime days –0.05 (–0.43, 0.34) –0.01 (–0.14, 0.11) 0.25 (–0.37, 0.87) 0.00 (–0.68, 0.68)
Diazinon
Ever use 0.04 (–0.34, 0.42) –0.12 (–0.24, 0.00) 0.07 (–0.54, 0.68) 0.09 (–0.61, 0.80)
Lifetime days 0.08 (–0.16, 0.33) –0.07 (–0.15, 0.00) 0.07 (–0.33, 0.46) 0.16 (–0.32, 0.58)
Dichlorvos
Ever use –0.31 (–0.82, 0.20) –0.15 (–0.32, –0.01) –0.14 (–0.96, 0.67) –0.66 (–1.57, 0.26)
Lifetime days –0.03 (–0.27, 0.21) –0.05 (–0.13, 0.02) –0.11 (–0.49, 0.27) –0.27 (–0.70, 0.15)
Dimethoate
Ever use 0.23 (–0.40, 0.86) –0.02 (–0.21, 0.18) –0.07 (–1.07, 0.92) –0.04 (–1.20, 1.12)
Lifetime days 0.10 (–0.33, 0.52) –0.01 (–0.15, 0.12) –0.01 (–0.68, 0.66) –0.08 (–0.86, 0.70)
Disulfoton
Ever use 0.03 (–0.53, 0.59) 0.07 (–0.11, 0.25) –0.40 (–1.30, 0.49) 0.57 (–0.47, 1.61)
Lifetime days 0.01 (–0.35, 0.37) 0.03 (–0.09, 0.14) –0.22 (–0.80, 0.36) 0.46 (–0.21, 1.14)
Ethoprop
Ever use –0.41 (–0.95, 0.12) –0.08 (–0.25, 0.09) –0.60 (–1.45, 0.24) –0.01 (–1.01, 0.99)
Lifetime days –0.28 (–0.62, 0.07) –0.06 (–0.17, 0.05) –0.36 (–0.91, 0.19) –0.08 (–0.72, 0.57)
Fonofos
Ever use 0.05 (–0.40, 0.50) –0.09 (–0.24, 0.05) 0.09 (–0.63, 0.81) –0.09 (–0.91, 0.73)
Lifetime days 0.06 (–0.21, 0.33) –0.04 (–0.13, 0.04) –0.04 (–0.48, 0.39) –0.05 (–0.54, 0.44)
Malathion
Ever use 0.28 (–0.16, 0.72) –0.02 (–0.16, 0.12) –0.09 (–0.79, 0.61) –0.70 (–1.51, 0.11)
Lifetime days –0.03 (–0.25, 0.19) –0.05 (–0.12, 0.02) 0.01 (–0.34, 0.36) –0.27 (–0.67, 0.14)
Parathion
Ever use 0.22 (–0.25, 0.68) –0.07 (–0.22, –0.08) –0.01 (–0.75, 0.73) 0.31 (–0.53, 1.15)
Lifetime days 0.25 (–0.04, 0.54) 0.01 (–0.08, 0.10) 0.03 (–0.43, 0.49) 0.17 (–0.34, 0.68)
Phorate
Ever use 0.47 (0.06, 0.88) 0.01 (–0.13, 0.14) 0.64 (–0.01, 1.29) 0.91 (0.16, 1.66)
Lifetime days 0.28 (0.04, 0.52) 0.01 (–0.06, 0.09) 0.51 (0.12, 0.89) 0.73 (0.29, 1.17)
Phosmet
Ever use –0.07 (–0.63, 0.49) –0.05 (–0.23, 0.13) –0.21 (–1.11, 0.69) –0.27 (–1.30, 0.75)
Lifetime days –0.09 (–0.43, 0.25) –0.01 (–0.13, 0.10) –0.10 (–0.65, 0.46) –0.04 (–0.68, 0.59)
Tebupirimfos
Ever use 0.71 (0.05, 1.37) 0.06 (–0.15, 0.27) 0.78 (–0.28, 1.84) –0.05 (–1.24, 1.13)
Lifetime days 0.43 (0.02, 0.84) 0.04 (–0.09, 0.17) 0.51 (–0.14, 1.17) 0.08 (–0.65, 0.80)
Terbufos
Ever use 0.20 (–0.18, 0.59) 0.05 (–0.07, 0.17) 0.21 (–0.41, 0.82) 0.16 (–0.54, 0.86)
Lifetime days 0.14 (–0.06, 0.34) 0.04 (–0.03, 0.10) 0.18 (–0.15, 0.51) 0.30 (–0.07, 0.67)
Tetrachlorvinphos
Ever use –0.40 (–1.03, 0.24) –0.05 (–0.24, 0.15) –0.04 (–1.06, 0.99) –0.36 (–1.50, 0.77)
Lifetime days –0.23 (–0.62, 0.16) –0.02 (–0.14, 0.10) 0.15 (–0.47, 0.77) –0.13 (–0.81, 0.56)
Carbamates
Aldicarb
Ever use 0.30 (–0.22, 0.83) –0.06 (–0.22, 0.11) –0.61 (–0.23, 1.44) 1.73 (0.74, 2.71)
Lifetime days 0.18 (–0.12, 0.49) –0.06 (–0.16, 0.03) 0.27 (–0.21, 0.75) 0.87 (0.31, 1.44)
Benomyl
Ever use 0.28 (–0.26, 0.82) –0.06 (–0.23, 0.11) 0.62 (–0.23, 1.48) 0.60 (–0.40, 1.60)
Lifetime days 0.11 (–0.24, 0.47) –0.07 (–0.18, 0.04) 0.44 (–0.12, 1.00) 0.39 (–0.27, 1.05)
Carbaryl
Ever use –0.10 (–0.54, 0.33) –0.13 (–0.26, 0.01) –0.30 (–0.99, 0.40) –0.62 (–1.40, 0.16)
Lifetime days 0.08 (–0.16, 0.33) –0.10 (–0.18, –0.02) –0.01 (–0.41, 0.38) –0.31 (–0.76, 0.13)
Carbofuran
Ever use –0.03 (–0.41, 0.35) –0.07 (–0.20, 0.04) –0.18 (–0.78, 0.43) –0.30 (–0.99, 0.40)
Lifetime days 0.00 (–0.24, 0.23) –0.04 (–0.11, 0.04) 0.03 (–0.35, 0.41) –0.08 (–0.52, 0.36)
Summary variables
Lifetime days to all OPs 0.22 (–0.06, 0.49) –0.02 (–0.10, 0.07) 0.31 (–0.12, 0.74) 0.53 (0.02, 1.02)
Lifetime days to all pesticides 0.19 (–0.19, 0.58) 0.10 (–0.22, 0.02) 0.53 (–0.08, 1.14) 0.75 (0.01, 1.50)
HPEEs (ever) 0.54 (0.10, 0.98) –0.01 (–0.15, 0.13) 0.02 (–0.68, 0.72) 0.16 (–0.63, 0.96)
Electrophysiological tests were adjusted for age, height, foot temperature, and state.
aScores have been multiplied by –1 so that lower scores indicate poorer test results.Starks et al.
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of the assumptions, methodological studies 
have shown that AHS participants provide 
accurate and reliable pesticide use and duration 
of pesticide exposure information (Blair et al. 
2002; Hoppin et al. 2002).
Another important difference between our 
study and those conducted previously is the 
age of the workers. The average age of partici-
pants in our study was 61 years, whereas the 
average age of participants in earlier studies 
ranged from 30 to approximately 55 years. It is 
possible that age or exposure duration potenti-
ates the effects of exposure and accounts for 
differences between studies. Also, contrary to 
the present study, none of the studies reviewed 
reported exclusion of participants with a past 
episode of pesticide poisoning.
In summary, the existing literature is rela-
tively small and inconsistent in methods and 
results. Important questions remain regarding 
the health outcomes most responsive to expo-
sure effects, possible differential effects of specific 
chemicals, and the actual pathophysiological 
process responsible for observed impairments.
One interesting finding of the present 
study was the observation of stronger asso-
ciations between pesticide use and NPx out-
comes than with the analogous quantitative 
measures. For example, we observed signifi-
cant adverse associations between abnormal 
toe vibration on NPx and two OP pesticides 
(dichlorvos and tetrachlorvinphos), but we 
did not observe associations between quan-
titative toe vibrotactile thresholds and these 
chemicals. Our a priori expectation was that 
quantitative measures would be as sensitive as 
NPx to PNS effects. Because the examiner was 
blinded to pesticide exposure status, we do not 
believe that observer bias accounts for these 
findings. It is possible that, despite consider-
able training of quantitative test administra-
tors, non  differential error was greater for the 
quantitative tests than for the NPx outcomes. 
Another possibility is that the NPx better cap-
tured relevant peripheral nerve impairment 
than did the quantitative measures.
Eligibility for the present study required 
completion of all AHS questionnaires, and 
individuals who were no longer farming at 
enrollment were less likely to meet this require-
ment (Montgomery et al. 2010). The reasons 
for leaving farming are many, but those with 
peripheral nerve impairment may have been 
more likely to leave farming than those with-
out. Thus, it is possible that loss from the sam-
ple of those most susceptible to the adverse 
effects of pesticide exposure attenuated the 
observed associations. Such selective survival 
may also lead to the inclusion of healthy older 
participants with longer pesticide use dura-
tions, creating the appearance of an associa-
tion between pesticide use and improved PNS 
function. Given the response rate of 39%, our 
sample may not have been representative of all 
AHS participants. However, on several impor-
tant characteristics, including age and total 
lifetime days of pesticide use, participants were 
similar to eligible non  participants, suggesting 
comparability between them.
Given the data complexity of 14 outcomes 
and > 100 exposures, we presented the results 
of numerous statistical tests. No formal cor-
rection for multiple comparisons was made, 
but efforts were made to reduce the number 
of outcomes where appropriate. For example, 
we combined six hand strength measures into 
a single hand strength metric, and we aver-
aged the vibrotactile thresholds of the domi-
nant and non  dominant great toes. However, 
given that we performed hundreds of statisti-
cal tests and observed significant associations 
in both positive and negative directions, some 
of our findings may be due to chance.
Previous studies of PNS function among 
pesticide applicators have included participants 
with past pesticide poisoning (28%, Cole et al. 
1998; 9%, London et al. 1998), a known cause 
of peripheral neuropathy (Lotti and Moretto 
2005). Associations were typically stronger 
among poisoned than among non  poisoned 
participants. Because we did not recruit par-
ticipants who reported a past diagnosis of 
pesticide poisoning at the most recent AHS 
interview, it is unlikely that adverse associations 
resulted from previous pesticide poisoning. 
Furthermore, our findings were unchanged by 
exclusion of the eight participants who reported 
a past diagnosis of pesticide poisoning at the 
time of AHS enrollment. It is also unlikely 
that current pesticide toxicity accounted for 
our results because evaluations were performed 
during the winter when pesticides were not 
applied. In addition to pesticides, pesticide 
applicators are potentially exposed to a num-
ber of other neurotoxicants, such as organic 
solvents and soldering and welding fumes. We 
assessed these agents at the time of neurological 
testing and evaluated whether they confounded 
the pesticide associations. We observed no evi-
dence of confounding of any PNS measure by 
these occupational exposures; however, we can-
not rule out the possibility of confounding by 
unmeasured neurotoxicants.
In this study of 678 licensed pesticide 
applicators with well-characterized lifetime 
exposure to OP pesticides, our findings provide 
evidence that long-term exposure to some OP 
pesticides may be associated with selected indi-
ces of poorer PNS function among pesticide 
applicators with no previous history of diag-
nosed pesticide poisoning. The most consistent 
associations were with the clinical NPx out-
comes, particularly toe proprioception, which 
was significantly associated with ever use of 
chlorpyrifos, coumaphos, dichlorvos, fonofos, 
phosmet, and tetrachlorvinphos. Furthermore, 
monotonic increases in ORs were observed for 
abnormal toe proprioception and chlorpyri-
fos, fonofos, and phosmet. Especially for this 
outcome, the number of pesticides with signifi-
cant adverse associations and the observation of 
dose–response relationships suggest that they 
are the result of long-term pesticide exposure 
rather than chance alone.
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